IP Library Granted Patent US 7,897,625
Granted Patent B2
US 7,897,625 · App. 12/099,924 · Granted Mar 1, 2011

Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases

Assignee: Sanofi-Aventis
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,625
App. No.
12/099,924
Granted
Mar 1, 2011
Kind
B2
Abstract

The invention relates to carbamoylbenzotriazole derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.

Claims (63)

1. A compound of the formula I

wherein:

W is —(C═O)—, —SO— or —SO 2 —;

R1 is X-aryl, X-heteroaryl, X—(C 5 -C 12 )-cycloalkyl or (C 8 -C 14 ) -bicycle, where aryl, heteroaryl, cycloalkyl or bicycle may be substituted one or more times by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, (C 1 -C 6 ) -alkylmercapto, amino, (C 1 -C 6 )-alkylamino, di-(C 2 -C 12 )-alkylamino, mono -(C 1 -C 6 )-alkylaminocarbonyl, di-(C 2 -C 8 )-alkylaminocarbonyl, (C 1 -C 6 ) -alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, trifluoromethyloxy, (C 1 -C 6 )-alkylsulfonyl, or aminosulfonyl, and may be substituted once by Y-aryl, Y-heteroaryl or Y—(C 3 -C 12 )-cycloalkyl, in which aryl, heteroaryl or cycloalkyl may be substituted one to three times by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, (C 1 -C 6 )-alkylmercapto, amino, (C 1 -C 6 )-alkylamino, di-(C 2 -C 12 )-alkylamino, mono-(C 1 -C 6 ) -alkylaminocarbonyl, di-(C 2 -C 8 )-alkylaminocarbonyl, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, trifluoromethyloxy, (C 1 -C 6 ) -alkylsulfonyl or aminosulfonyl;

X is CH 2 , which may be substituted once by halogen, methyl or hydroxy;

Y is a bond, (C 1 -C 3 )-alkylene, —O— or —NH—;

R2, R3, R4, R5 are identically or differently hydrogen, halogen, (C 1 -C 6 )-alkyl, (C 1 -C 3 )-haloalkyl, (C 1 -C 3 )-alkyloxy-(C 1 -C 3 )-alkylene, hydroxy, phenoxy, NR6R7, cyano, nitro, COOR6, CO—NR6R7, —S—R6, —SO—R6, —SO 2 —R6, aminosulfonyl, pentafluorosulfanyl, aryl, heteroaryl, O-heteroaryl, (C 3 -C 12 ) -cycloalkyl, CO—R6, CO—NR6R7, O—CO—NR6R7, O—CO—(C 1 -C 6 )-alkylene-CO—O—(C1-C 6 )-alkyl, O—CO—(C 1 -C 6 )-alkylene-CO—OH, O—CO—(C 1 -C 6 )-alkylene -CO—NR6R7 or unsubstituted or mono- or poly-F-substituted (C 1 -C 6 )-alkyloxy; and

R6, R7 are identically or differently hydrogen, (C 1 -C 6 )-alkyl or benzyl; or

a tautomer thereof or a physiologically tolerated salt thereof.

2. The compound of the formula I as claimed in claim 1 , wherein W is —(C═O)—.

3. The compound of the formula I as claimed in claim 1 , wherein:

W is —(C═O)—;

R1 is X-aryl, X-heteroaryl or (C 8 -C 14 )-bicycle, where aryl, heteroaryl, cycloalkyl or bicycle may be substituted one or more times by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, (C 1 -C 6 )-alkylmercapto, amino, (C 1 -C 6 )-alkylamino, di-(C 2 -C 12 )-alkylamino, mono-(C 1 -C 6 ) -alkylaminocarbonyl, di-(C 2 -C 8 )-alkylaminocarbonyl, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, trifluoromethyloxy, (C 1 -C 6 ) -alkylsulfonyl, or aminosulfonyl, and may be substituted once by Y-aryl, Y-heteroaryl, or Y—(C 3 -C 12 )-cycloalkyl, in which aryl, heteroaryl or cycloalkyl may be substituted once or twice by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, amino, (C 1 -C 6 )-alkylamino, di-(C 2 -C 12 )-alkylamino, (C 1 -C 6 ) -alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, or trifluoromethyloxy;

X is —CH 2 —, which may be substituted once by halogen, methyl or hydroxy;

Y is a bond, —O— or —NH—; and

R2, R3, R4, R5 are identically or differently hydrogen, halogen, (C 1 -C 6 )-alkyl, trifluoromethyl, hydroxy, amino, cyano, phenoxy, (C 1 -C 6 )-alkylcarbonyl, (C 1 -C 6 ) -alkylsulfonyl, pentafluorosulfanyl, or unsubstituted or mono- or poly-F-substituted (C 1 -C 3 )-alkyloxy; or

a tautomer thereof or a physiologically tolerated salt thereof.

4. The compound of the formula I as claimed in claim 1 , wherein:

W is —(C═O)—;

R1 is X-phenyl, X-heteroaryl, or bicycle, where aryl, heteroaryl or bicycle may be substituted one or more times by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, trifluoromethyloxy, (C 1 -C 6 )-alkylsulfonyl or aminosulfonyl, and may be substituted once by Y-phenyl or Y-heteroaryl, in which phenyl or heteroaryl may be substituted once or twice by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 ) -alkyloxy, hydroxy, amino, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 ) -alkylcarbonyl, cyano, trifluoromethyl or trifluoromethyloxy;

X is —CH 2 —, which may be substituted by fluorine, methyl or hydroxy;

Y is a bond; and

R2, R3, R4, R5 are identically or differently hydrogen, halogen, (C 1 -C 6 )-alkyl, trifluoromethyl, hydroxy, amino, cyano, phenoxy, (C 1 -C 6 )-alkylcarbonyl or unsubstituted or mono- or poly-F-substituted (C 1 -C 3 )-alkyloxy; or

a tautomer thereof or a physiologically tolerated salt thereof.

5. The compound of the formula I as claimed in claim 1 , wherein:

W is —(C═O)—;

R1 is X-phenyl, X-heteroaryl, or bicycle of the formula Ia

 wherein n=1 or 2, where phenyl, heteroaryl or bicycle of the formula Ia may be substituted one or more times by halogen, (C 1 -C 6 )-alkyl, (C1-C6)-alkyloxy, hydroxy, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, trifluoromethyloxy, (C 1 -C 6 )-alkylsulfonyl or aminosulfonyl, and may be substituted once by Y-phenyl or Y-heteroaryl, in which phenyl or heteroaryl may be substituted once or twice by halogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, amino, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 ) -alkylcarbonyl, cyano, trifluoromethyl or trifluoromethyloxy;

X is —CH 2 —, which may be substituted by fluorine, methyl or hydroxy;

Y is a bond; and

R2, R3, R4, R5 are identically or differently hydrogen, halogen, (C 1 -C 6 )-alkyl, trifluoromethyl, hydroxy, amino, cyano, phenoxy, (C 1 -C 6 )-alkylcarbonyl or unsubstituted or mono- or poly-F-substituted (C 1 -C 3 )-alkyloxy; or

a tautomer thereof or a physiologically tolerated salt thereof.

6. The compound of the formula I as claimed in claim 1 , wherein:

W is —(C═O)—;

R1 is X-phenyl, X-heteroaryl, or bicycle of the formula Ia

 wherein n=1 or 2, where phenyl, heteroaryl or bicycle of the formula Ia may be substituted one or more times by halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, cyano, nitro, trifluoromethyl, trifluoromethyloxy, (C 1 -C 6 )-alkylsulfonyl or aminosulfonyl, and may be substituted once by Y-phenyl or Y-heteroaryl, in which phenyl or heteroaryl may be substituted once or twice by halogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 )-alkyloxy, hydroxy, amino, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 ) -alkylcarbonyl, cyano, trifluoromethyl or trifluoromethyloxy;

X is —CH 2 — which may be substituted by methyl;

Y is a bond;

R2, R3, R4, R5 are identically or differently hydrogen, halogen, (C 1 -C 6 )-alkyl, trifluoromethyl, hydroxy, amino, cyano, phenoxy, (C 1 -C 6 )-alkylcarbonyl or unsubstituted or mono- or poly-F-substituted (C 1 -C 3 )-alkyloxy.

7. The compound of the formula I as claimed in claim 1 , wherein:

W is —(C═O)—;

R1 is X-phenyl, X-thienyl, X-furan, X-benzothienyl, indanyl or tetrahydronaphthyl, where phenyl, thienyl, furan, benzothienyl, indanyl or tetrahydronaphthyl may be substituted once, twice or three times by F, Cl, Br, methyl, ethyl, isopropyl, methoxy, ethoxy, hydroxy, CO—OCH 3 , CO—CH 3 , cyano, nitro, trifluoromethyl or trifluoromethyloxy and may be substituted once by Y-phenyl, Y-thienyl, Y-pyridyl or Y-pyrazolyl, in which phenyl, thienyl, pyridyl or pyrazolyl may be substituted once or twice by F, Cl, Br, methyl, methoxy, hydroxy, amino, CO—OCH 3 , CO—CH 3 , cyano, trifluoromethyl or trifluoromethyloxy;

X is —CH 2 — which may be substituted by methyl;

Y is a bond;

R2, R3, R4, R5 are identically or differently hydrogen, F, Cl, methoxy, trifluoromethyl, cyano or phenoxy.

8. The compound of the formula I as claimed in claim 1 , wherein:

W is —(C═O)—;

R1 is X-phenyl, X-thienyl, X-furan, X-benzothienyl or indanyl, where phenyl, thienyl, X-furan, X-benzothienyl may be substituted once or twice by F, Cl, Br, methyl, isopropyl, methoxy, cyano or trifluoromethyl and may be substituted once by Y-phenyl, Y-thienyl, Y-pyridyl or Y-pyrazolyl, in which phenyl may be substituted by Cl;

X is —CH 2 —, which may be substituted by methyl;

Y is a bond;

R2 is hydrogen, F or Cl;

R3 is hydrogen, F, Cl, methoxy, trifluoromethyl, cyano or phenoxy;

R4 is hydrogen, F, Cl, methoxy, trifluoromethyl, cyano or phenoxy;

R5 is hydrogen, F or Cl.

9. The compound of the formula I as claimed in claim 1 , wherein R2, R3, R4, R5 are hydrogen.

10. The compound of the formula I as claimed in claim 1 , wherein:

R2, R3, R5 are hydrogen;

and

R4 is not hydrogen; or

R2, R4, R5 are hydrogen;

and

R3 is not hydrogen.

11. A pharmaceutical composition comprising one or more compounds of the formula I as claimed in claim 1 or a tautomer thereof or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

Assignments (2)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2008
From: PETRY, STEFAN; ZOLLER, GERHARD; TENNAGELS, NORBERT; MULLER, GUNTER
To: SANOFI-AVENTIS
Reel/Frame 021314/0168 →
Priority Claims (1)
DE 10 2005 049 953 · Oct 19, 2005 · national
Continuity (2)
Continuation PCTEP2006009857 · Oct 12, 2006
Related Publication 20080287503A1 · Nov 20, 2008